An observational study in Chronic Obstructive Pulmonary Disease, sponsored by Hopital du Sacre-Coeur de Montreal. Suspended at 5 sites in Canada. Open to participants aged 40 Years to 90 Years. Per ClinicalTrials.gov, last updated 2019-03-15.
Sponsored by Hopital du Sacre-Coeur de Montreal · Observational
The present study aims to assess the prevalence and impact of comorbid psychiatric disorders among patients with chronic obstructive pulmonary disease (COPD) undergoing pulmonary rehabilitation (PR), in order to determine the effects of psychiatric comorbidity on exercise tolerance and physical activity post-PR and HRQoL, as well as to determine the processes by which these psychiatric disorders may impact on these patient behaviours.
3,303 studies on the registry are indexed under Lung Diseases; 355 are open to participants now.
This study's planned enrollment of 360 is above the median of 157 across 929 observational studies indexed under Lung Diseases.
Browse Lung Diseases studies →Hopital du Sacre-Coeur de Montreal is the lead sponsor of 21 studies on the registry; 2 are open to participants now.
Counted across the registry records on this site, refreshed daily.
COPD patients will be consecutively recruited at entry in one of six PR programs in the Montreal area: Hôpital du Sacré-Coeur de Montréal (HSCM), Mount Sinai Hospital, Hôtel-Dieu de Montréal (CHUM), and Hôpital Charles-LeMoyne, Jewish Rehabilitation Hospital of Laval, McGill University Health Centre (MUHC).
Exclusion Criteria:
They will be excluded if:
The change in exercise tolerance at 1-year post-PR
Exercise tolerance will be measured with the 6-minute walking test (6MWT).
Time frame: Participants will be evaluated at 3 time points: (1) post-PR; (2) at 6-mo; (3) at 12-mo follow-up.
The change in health-related quality of life (HRQoL) at 1-year post-PR
HRQoL will be measured with the 12-Item Short Form Survey and the COPD Assessment Test
Time frame: Participants will be evaluated at 3 time points: (1) post-PR; (2) at 6-mo; (3) at 12-mo follow-up.
This study is suspended, as verified in Mar 2019. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Hopital du Sacre-Coeur de Montreal